Hyperliquid Strategies Inc (NASDAQ:PURR – Get Free Report) was the recipient of unusually large options trading on Wednesday. Stock investors purchased 104,320 call options on the company. This is an increase of 416% compared to the average volume of 20,203 call options.
Analyst Upgrades and Downgrades
PURR has been the subject of several recent research reports. Weiss Ratings raised Hyperliquid Strategies from a “sell (d)” rating to a “sell (d+)” rating in a research note on Wednesday, June 3rd. Cantor Fitzgerald lifted their target price on shares of Hyperliquid Strategies from $8.00 to $18.40 and gave the stock an “overweight” rating in a research note on Wednesday, July 1st. Chardan Capital reaffirmed a “buy” rating and set a $9.75 target price on shares of Hyperliquid Strategies in a report on Friday, June 12th. Finally, Maxim Group started coverage on shares of Hyperliquid Strategies in a research report on Friday, April 24th. They set a “buy” rating and a $10.00 price target on the stock. Three investment analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $12.72.
Read Our Latest Analysis on Hyperliquid Strategies
Institutional Investors Weigh In On Hyperliquid Strategies
Hyperliquid Strategies Trading Up 30.2%
NASDAQ:PURR traded up $2.17 during trading hours on Wednesday, hitting $9.38. The company had a trading volume of 43,255,237 shares, compared to its average volume of 8,635,699. Hyperliquid Strategies has a 1 year low of $3.01 and a 1 year high of $11.62. The firm has a market capitalization of $1.35 billion, a P/E ratio of -1.25 and a beta of 1.71. The business’s 50-day moving average price is $7.54.
About Hyperliquid Strategies
Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. Hyperliquid Strategies Inc, formerly known as Sonnet BioTherapeutics Holdings Inc, is based in NEW YORK.
Featured Stories
- Five stocks we like better than Hyperliquid Strategies
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
Receive News & Ratings for Hyperliquid Strategies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hyperliquid Strategies and related companies with MarketBeat.com's FREE daily email newsletter.
